🚀 VC round data is live in beta, check it out!
- Public Comps
- 4DMedical
4DMedical Valuation Multiples
Discover revenue and EBITDA valuation multiples for 4DMedical and similar public comparables like UFP Technologies, MicroPort EP, AtriCure, Wandong Medical and more.
4DMedical Overview
About 4DMedical
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
Founded
2012
HQ

Employees
124
Website
Financials (LTM)
EV
$2B
4DMedical Financials
4DMedical reported last 12-month revenue of $5M and negative EBITDA of ($20M).
In the same LTM period, 4DMedical generated ($7M) in gross profit, ($20M) in EBITDA losses, and had net loss of ($46M).
Revenue (LTM)
4DMedical P&L
In the most recent fiscal year, 4DMedical reported revenue of $4M and EBITDA of ($17M).
4DMedical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5M | XXX | $4M | XXX | XXX | XXX |
| Gross Profit | ($7M) | XXX | $4M | XXX | XXX | XXX |
| Gross Margin | (135%) | XXX | 92% | XXX | XXX | XXX |
| EBITDA | ($20M) | XXX | ($17M) | XXX | XXX | XXX |
| EBITDA Margin | (369%) | XXX | (430%) | XXX | XXX | XXX |
| EBIT Margin | (437%) | XXX | (571%) | XXX | XXX | XXX |
| Net Profit | ($46M) | XXX | ($20M) | XXX | XXX | XXX |
| Net Margin | (862%) | XXX | (487%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
4DMedical Stock Performance
4DMedical has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
4DMedical's stock price is $2.76.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -0.1% | XXX | XXX | XXX | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free Trial4DMedical Valuation Multiples
4DMedical trades at 286.8x EV/Revenue multiple, and (77.8x) EV/EBITDA.
EV / Revenue (LTM)
4DMedical Financial Valuation Multiples
As of March 26, 2026, 4DMedical has market cap of $2B and EV of $2B.
Equity research analysts estimate 4DMedical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
4DMedical has a P/E ratio of (34.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 286.8x | XXX | 382.1x | XXX | XXX | XXX |
| EV/EBITDA | (77.8x) | XXX | (88.9x) | XXX | XXX | XXX |
| EV/EBIT | (65.6x) | XXX | (66.9x) | XXX | XXX | XXX |
| EV/Gross Profit | (212.6x) | XXX | 415.4x | XXX | XXX | XXX |
| P/E | (34.0x) | XXX | (80.1x) | XXX | XXX | XXX |
| EV/FCF | (75.1x) | XXX | (65.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified 4DMedical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


4DMedical Margins & Growth Rates
4DMedical's revenue in the last 12 month grew by 222%.
4DMedical's revenue per employee in the last FY averaged $0.0M.
4DMedical's rule of 40 is (147%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
4DMedical's rule of X is 187% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
4DMedical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 222% | XXX | 47% | XXX | XXX | XXX |
| EBITDA Margin | (369%) | XXX | (430%) | XXX | XXX | XXX |
| EBITDA Growth | (28%) | XXX | 17% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (147%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 187% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 28% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 574% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | 15% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 915% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
4DMedical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| UFP Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| MicroPort EP | XXX | XXX | XXX | XXX | XXX | XXX |
| AtriCure | XXX | XXX | XXX | XXX | XXX | XXX |
| Wandong Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Axogen | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
4DMedical M&A Activity
4DMedical acquired XXX companies to date.
Last acquisition by 4DMedical was on XXXXXXXX, XXXXX. 4DMedical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by 4DMedical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free Trial4DMedical Investment Activity
4DMedical invested in XXX companies to date.
4DMedical made its latest investment on XXXXXXXX, XXXXX. 4DMedical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by 4DMedical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout 4DMedical
| When was 4DMedical founded? | 4DMedical was founded in 2012. |
| Where is 4DMedical headquartered? | 4DMedical is headquartered in Australia. |
| How many employees does 4DMedical have? | As of today, 4DMedical has over 124 employees. |
| Is 4DMedical publicly listed? | Yes, 4DMedical is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of 4DMedical? | 4DMedical trades under 4DX ticker. |
| When did 4DMedical go public? | 4DMedical went public in 2020. |
| Who are competitors of 4DMedical? | 4DMedical main competitors are UFP Technologies, MicroPort EP, AtriCure, Wandong Medical. |
| What is the current market cap of 4DMedical? | 4DMedical's current market cap is $2B. |
| What is the current revenue of 4DMedical? | 4DMedical's last 12 months revenue is $5M. |
| What is the current revenue growth of 4DMedical? | 4DMedical revenue growth (NTM/LTM) is 222%. |
| What is the current EV/Revenue multiple of 4DMedical? | Current revenue multiple of 4DMedical is 286.8x. |
| Is 4DMedical profitable? | No, 4DMedical is not profitable. |
| What is the current EBITDA of 4DMedical? | 4DMedical has negative EBITDA and is not profitable. |
| What is 4DMedical's EBITDA margin? | 4DMedical's last 12 months EBITDA margin is (369%). |
| What is the current EV/EBITDA multiple of 4DMedical? | Current EBITDA multiple of 4DMedical is (77.8x). |
| What is the current FCF of 4DMedical? | 4DMedical's last 12 months FCF is ($21M). |
| What is 4DMedical's FCF margin? | 4DMedical's last 12 months FCF margin is (382%). |
| What is the current EV/FCF multiple of 4DMedical? | Current FCF multiple of 4DMedical is (75.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.